Procter & Gamble Health Limited (NSE:PGHL)

Procter & Gamble Health Income Statement

Financials in millions INR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Operating Revenue	11,595	11,513	12,296	11,144	10,087	8,886
Revenue	11,595	11,513	12,296	11,144	10,087	8,886
Revenue Growth (YoY)	-6.26%	-6.37%	10.34%	10.48%	13.52%	-4.10%
Cost of Revenue	3,288	3,425	3,834	3,531	3,245	3,206
Gross Profit	8,308	8,087	8,463	7,614	6,842	5,680
Selling, General & Admin	2,434	2,682	2,811	2,776	2,421	2,460
Other Operating Expenses	2,337	2,340	2,412	2,141	1,943	1,111
Operating Expenses	5,024	5,296	5,504	5,188	4,669	3,789
Operating Income	3,284	2,791	2,959	2,426	2,173	1,892
Interest Expense	-6.5	-7.2	-7.7	-4.2	-8	-
Interest & Investment Income	117.3	117.3	143.3	110.7	150.6	572.5
Currency Exchange Gain (Loss)	2.7	2.7	3.4	-6.9	-8.9	26.7
Other Non Operating Income (Expenses)	-3.6	36.3	30.1	21.2	30.4	-283.96
EBT Excluding Unusual Items	3,393	2,940	3,128	2,546	2,337	2,207
Gain (Loss) on Sale of Assets	-5.1	-5.1	7.1	-5.4	-4.2	-32.5
Asset Writedown	-201.9	-201.9	7.3	-7.3	-	-
Other Unusual Items	-	-	-	-	-	24.2
Pretax Income	3,186	2,733	3,142	2,534	2,333	2,199
Income Tax Expense	820.7	723.4	847.3	608.5	564.8	539.42
Earnings From Continuing Operations	2,366	2,010	2,295	1,925	1,768	1,659
Net Income	2,366	2,010	2,295	1,925	1,768	1,659
Net Income to Common	2,366	2,010	2,295	1,925	1,768	1,659
Net Income Growth	4.38%	-12.42%	19.19%	8.89%	6.56%	4.51%
Shares Outstanding (Basic)	17	17	17	17	17	17
Shares Outstanding (Diluted)	17	17	17	17	17	17
Shares Change (YoY)	-0.00%	-	-	-	-0.08%	0.08%
EPS (Basic)	142.52	121.08	138.24	115.98	106.51	99.87
EPS (Diluted)	142.44	121.00	138.00	115.98	106.51	99.81
EPS Growth	4.50%	-12.32%	18.99%	8.89%	6.72%	4.36%
Free Cash Flow	2,611	2,066	1,935	1,316	1,947	1,414
Free Cash Flow Per Share	157.29	124.44	116.58	79.28	117.28	85.11
Dividend Per Share	140.000	110.000	95.000	52.500	40.000	28.000
Dividend Growth	40.00%	15.79%	80.95%	31.25%	42.86%	16.67%
Gross Margin	71.64%	70.25%	68.82%	68.32%	67.83%	63.92%
Operating Margin	28.32%	24.24%	24.06%	21.77%	21.54%	21.29%
Profit Margin	20.40%	17.46%	18.66%	17.28%	17.53%	18.67%
Free Cash Flow Margin	22.52%	17.94%	15.74%	11.81%	19.30%	15.91%
EBITDA	3,506	3,034	3,188	2,648	2,424	2,088
EBITDA Margin	30.23%	26.35%	25.92%	23.76%	24.03%	23.50%
D&A For EBITDA	222.2	243	229	222.1	251.1	196.33
EBIT	3,284	2,791	2,959	2,426	2,173	1,892
EBIT Margin	28.32%	24.24%	24.06%	21.77%	21.54%	21.29%
Effective Tax Rate	25.76%	26.47%	26.97%	24.02%	24.21%	24.53%
Revenue as Reported	11,712	11,669	2,480	11,276	10,268	9,225
Advertising Expenses	-	526.5	744.9	1,095	874.1	-

Source: S&P Capital IQ. Standard template. Financial Sources.